🔎 Trials Near Me

Utama › Skizofrenia › Illinois › Chicago

Kajian klinikal Skizofrenia di Chicago, IL

21 kajian untuk Skizofrenia sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

Mengambil pesertaSukarelawan sihat dialu-alukan
  • The University of Chicago, Chicago
Umur 18 hingga 59 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07853807

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Mengambil pesertaFasa 1
  • Uptown Research Institute, Chicago
Umur 18 hingga 55 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Mengambil pesertaFasa 3
  • Local Institution - 0067, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07686263

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Mengambil pesertaFasa 3
  • Neurocrine Clinical Site, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07114874

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Mengambil pesertaFasa 3
  • Local Institution - 0175, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Umur 5 hingga 17 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Mengambil pesertaFasa 2
  • Re:Cognition Health - Chicago, Chicago
Umur 18 hingga 55 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07410507

52-week Open Label Safety-Tolerability Study

Mengambil pesertaFasa 3
  • Pillar Clinical Research, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Mengambil pesertaFasa 3
  • Local Institution - 0122, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Umur 13 hingga 17 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Mengambil pesertaFasa 1
  • Uptown Research Institute, Chicago
Umur 18 hingga 55 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Mengambil pesertaFasa 2
  • Clinical Site, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07459647

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Mengambil pesertaFasa 3
  • Alkermes Investigator Site, Chicago
Umur 10 hingga 17 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05303064

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

Mengambil pesertaFasa 2
  • Uptown Research Institute LLC, Chicago
  • Pillar Clinical Research LLC, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Mengambil pesertaFasa 3
  • Pillar Clinical Research, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Mengambil pesertaFasa 2
  • Uptown Research Institute, Chicago
Umur 18 hingga 55 · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07191483

A Study to Evaluate the Effect of KarXT on Urological Safety

Mengambil pesertaFasa 4
  • Uptown Research Institute, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT07221877

CLOZAPINE Response in Biotype-1

Mengambil pesertaFasa 4
  • University of Chicago, Chicago
Umur 18 hingga 60 · Semua jantina · Dikemas kini 11 Mei 2026 · NCT04580134

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Mengambil pesertaKajian pemerhatian
  • University of Chicago Medical Center, Chicago
Umur 18 hingga 40 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Mengambil pesertaFasa 3
  • Neurocrine Clinical Site, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 6 Mac 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

Mengambil pesertaFasa 3
  • Vanda Investigational Site, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 12 Jan 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

Mengambil pesertaFasa 2
  • Site 5056, Chicago
Umur 21 hingga 55 · Semua jantina · Dikemas kini 26 Dis 2025 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • Reviva site, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 19 Dis 2024 · NCT05184335

Kajian Skizofrenia di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.